Biogen (BIIB) Options Chain & Prices $142.75 +1.77 (+1.26%) Closing price 04:00 PM EasternExtended Trading$141.51 -1.24 (-0.87%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BIIB Put and Call Options List 1/15/2027 12/18/2026 1/16/2026 9/19/2025 7/18/2025 6/20/2025 4/17/2025 3/21/2025 2/28/2025 2/21/2025 2/14/2025 2/7/2025 1/31/2025 1/24/2025 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export to Excel ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades1/24/2025$115.00$0.003Put10 - - 0(+0)73.23% (+23.26%)-0.00103811/24/2025$125.00$0.021Put20 - - 2(+1)56.19% (+16.54%)-0.00915211/24/2025$133.00$0.173Put1 - 12(+2)43.44% (+11.00%)-0.07082711/24/2025$135.00$0.313Put12 - 116(+3)40.65% (+9.64%)-0.12211131/24/2025$136.00$5.319Call2 - - 1(+0)39.40% (+9.00%)0.84153811/24/2025$137.00$0.578Put1651129(+1)38.27% (+8.40%)-0.20826551/24/2025$138.00$0.787Put9011312(-5)37.30% (+7.86%)-0.268271251/24/2025$139.00$1.067Put7 - 143(+2)36.54% (+7.42%)-0.34008961/24/2025$139.00$2.957Call151921(+21)36.54% (+7.42%)0.66391561/24/2025$140.00$1.433Put120121366(+12)36.00% (+7.10%)-0.42171539 Get the Latest News and Ratings for BIIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter. 1/24/2025$140.00$2.319Call3 - 346(+13)36.00% (+7.10%)0.58372811/24/2025$141.00$1.897Put2210 - 47(+18)35.73% (+6.92%)-0.50894151/24/2025$141.00$1.778Call2112520(+20)35.73% (+6.92%)0.498123111/24/2025$142.00$2.462Put3 - 210(+5)35.73% (+6.89%)-0.59598521/24/2025$142.00$1.336Call2141570(+26)35.73% (+6.89%)0.412675111/24/2025$143.00$3.123Put21 - 15(+2)35.99% (+7.01%)-0.67709921/24/2025$143.00$0.990Call2051412(+12)35.99% (+7.01%)0.33296671/24/2025$144.00$0.728Call3413310(+2)36.49% (+7.25%)0.26303551/24/2025$145.00$4.685Put1 - - 69(+12)37.18% (+7.60%)-0.80707111/24/2025$145.00$0.533Call4491345(-5)37.18% (+7.60%)0.204711211/24/2025$146.00$0.392Call281684(+2)38.04% (+8.03%)0.157885101/24/2025$148.00$0.215Call1711417(+1)40.08% (+9.02%)0.09312681/24/2025$149.00$0.162Call14 - 1215(+0)41.21% (+9.55%)0.07167931/24/2025$150.00$0.123Call281210124(+2)42.38% (+10.10%)0.055399111/24/2025$152.50$0.064Call11 - 11(+0)45.45% (+11.47%)0.02983111/24/2025$155.00$0.035Call40 - - 97(+0)48.57% (+12.82%)0.01671531/24/2025$160.00$0.012Call531102(+7)54.80% (+15.41%)0.0058831/24/2025$165.00$0.005Call20 - - 41(+0)60.78% (+17.79%)0.0023693End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Regeneron Pharmaceuticals Options Chain Alnylam Pharmaceuticals Options Chain United Therapeutics Options Chain Neurocrine Biosciences Options Chain Incyte Options Chain BioMarin Pharmaceutical Options Chain Exelixis Options Chain Exact Sciences Options Chain Repligen Options Chain Halozyme Therapeutics Options Chain Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:BIIB) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
